[The surgical treatment of cancer of the middle lobe of the lung].
The immediate and long-term results of surgical treatment for cancer of the middle lobe of the lung in 84 patients are discussed. Radical procedure was used in 65 (77.4%) patients. Postoperative lethality was 6.1% (4 cases out of 65). 30.2% survived over 5 years. Regional lymphatic node involvement was found to significantly affect the end results. At zero involvement, 5-years survival was 38.7% whereas at involvement 1-2, it dropped to 8.3%. With regional nodes intact, midlobectomy was survived for more than 5 years by 20.0%, bilobectomy--71.4%, and pneumonectomy--35.7%. Maximal advantage is assured by bilobectomy since it allows for adequate lymphadendissection, midlobectomy being not radical enough for surgical treatment of lung cancer.
Rukosuev
A A
AA
Kotliarov
E V
EV
D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D000328:Adult; D000368:Aged; D018288:Carcinoma, Small Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods / Q000401:mortality; D011183:Postoperative Complications / Q000453:epidemiology / Q000401:mortality
Khirurgicheskoe lechenie raka sredneĭ doli legkogo.